Table 1.
Menopausal Status | Estrogen Receptor Status* | Surgical Treatment# | Chemotherapy† | Radiation Therapy‡ | Endocrine Therapy§ |
---|---|---|---|---|---|
Premenopausal | ER + | Mastectomy or Breast conserving | Chemotherapy† | Radiation‡ | Tamoxifen Ovarian suppression with or without an aromatase inhibitor |
Postmenopausal | ER + | Mastectomy or Breast conserving | Chemotherapy† | Radiation‡ | Tamoxifen or aromatase inhibitor |
Premenopausal Or Postmenopausal | ER − | Mastectomy or Breast conserving | Chemotherapy† | Radiation‡ |
Estrogen-receptor (ER) status (ER positive (ER+) or ER negative (ER−);
Surgical Treatment: Considered based upon tumor size;
Chemotherapy: May occur either before (neoadjuvant) or after surgical treatment depending upon a variety of clinical, pathologic, and genetic factors;
Radiation Therapy: Considered based upon surgical procedures and stage of disease;
Endocrine Therapy: Considered when the tumor expresses either the estrogen or progesterone receptor